News Daewoong Co., Ltd.

Equities

A003090

KR7003090008

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
17,200 ^KRW	-3.15%		-7.68%	-16.71%

Mar. 08	Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 15	Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08	CI
Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia	Feb. 15	MT
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	Feb. 05	CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	Jan. 31	CI
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.	Jan. 30	CI
Zydus Unit, Daewoong Pharma to Co-Develop, Commercialize Leuprolide Acetate in US	Dec. 11	MT
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.	Nov. 03	CI
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia	23-08-30	MT
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Daewoong Pharmaceutical's Nabota Surpasses 600,000 Customers in the US	23-08-02	MT
Daewoong Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.	23-07-27	CI
Daewoong Co., Ltd. authorizes a Buyback Plan.	23-07-26	CI
Avacta sees shares rise on new equity payment for South Korea venture	23-06-05	AN
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08	CI
An Unknown buyer completed the acquisition of 66.2% stake in Palmpack Co., Ltd. from Daewoong Co., Ltd..	23-02-27	CI
Sonoma Pharmaceuticals Signs Distribution Deal With Daewoong Pharmaceutical to Sell Skin Products in South Korea	23-01-31	MT
Oncorus, Daewoong Pharmaceutical to Develop Lipid Nanoparticle Formulations for mRNA Drug Candidate; Shares Surge	23-01-04	MT
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Daewoong Co., Ltd.

Equities

A003090

KR7003090008

Summary

Filters